A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma ...
Trastuzumab has revolutionised the treatment of HER2-positive early-stage breast cancer and is now standard of care in combination with chemotherapy for patients with tumours larger than 1 cm. However ...